Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RTX Interim / Quarterly Report 2023

May 7, 2024

3413_rns_2024-05-07_89fbb4c3-d874-4ac6-a8f1-7ff9660ed557.pdf

Interim / Quarterly Report

Open in viewer

Opens in your device viewer

Interim report for Q2 and H1 2023/24

(the period 01.10.2023 - 31.03.2024)

Announcement

to Nasdaq Copenhagen A/S and the media

Nørresundby, 7 May 2024

Announcement no. 25/2024

No. of pages: 15

Q2 meets expectations, with growing orders and sales, in a market, where customer inventories are normalizing and reordering is beginning to pick up.

"The results for Q2 are in line with our expectations for the quarter, reaching sales of DKK 125 million and trimming inventory by DKK 8 million during the quarter. In Q2, we furthermore see an increase in our order intake, indicating a shift towards more typical market dynamics, characterized by shorter order horizons and priority on inventory reductions.

2023/24 is indeed a challenging year for RTX, and in Q2 we have seen business gradually improving. We expect improvements to continue in the coming quarters, and despite some uncertainty we maintain our outlook for the year, as previously communicated in the 2022/23 annual report."

Peter Røpke, CEO

Highlights

  • Revenue in Q2 reached DKK 125 million, which is within the expected range of DKK 120-130 million, as communicated in the Q1 report, showing an increase of DKK 43 million (53 %) compared to Q1 2023/24.
  • Q2 showed a significant increase in new orders, indicating a gradually normalization in the market.
  • EBITDA reached DKK 1 million for the quarter, compared to DKK -31 million in Q1 2023/24.
  • Inventory decreased by DKK 8 million in Q2 as we received the last components ordered two years ago. Further reductions will follow throughout the year.
  • Q2 showed a negative cash flow of DKK 22 million, whereof DKK 9 million are related to the share buyback program.
  • During H1 2023/24, DKK 12 of 20 million in the current Share Buy Back program was utilized.

Outlook

During Q2, we witnessed an increase in new orders compared to the previous quarters. We therefore maintain the communicated outlook for the financial year, despite some uncertainty in the latest quarter, particularly in ProAudio.

  • Revenue DKK 580-630 million
  • EBITDA DKK 45-60 million
  • EBIT DKK 5-20 million

Investor and analyst conference call

On Tuesday, 7 May 2024 at 16:15 pm CET, RTX will hold a conference call for investors and analysts hosted by Danske Bank.

To register for the conference call, please e-mail [email protected].

RTX A/S Strømmen 6, DK-9400 Nørresundby, Denmark • Tel +45 96 32 23 00 • Fax +45 96 32 23 10 • VAT DK 17 00 21 47 • Web www.rtx.dk • E-mail [email protected]

RTX


RTX interim report for Q2 and H1 2023/24

Group Financial Highlights and Key Ratios

(non-audited)

Amounts in DKK million Q2 2023/24 Q2 2022/23 H1 2023/24 H1 2022/23 FY 2022/23
Income statement items
Revenue 125.2 180.0 207.1 387.5 782.8
Gross Profit 57.1 74.2 88.9 175.6 358.4
Gross Margin % 45.6% 41.2% 42.9% 45.3% 45.8%
EBITDA 0.9 7.8 -29.5 49.8 107.5
EBITDA % 0.7% 4.3% -14.3% 12.9% 13.7%
Operating profit/loss (EBIT) -9.6 -1.9 -50.8 30.4 67.9
Net financials 1.8 -1.8 -1.4 -11.6 -8.7
Profit/loss before tax -7.8 -3.7 -52.2 18.8 59.2
Profit/loss for the period -6.1 -2.9 -40.7 14.6 46.7
Balance sheet items
Net liquidity position(1) 87.2 96.3 87.2 96.3 137.7
Total assets 467.1 547.0 467.1 547.0 578.1
Equity 325.6 346.5 325.6 346.5 377.7
Liabilities 141.5 200.5 141.5 200.5 201.0
Other key figures
Development cost financed by RTX before capitalization 32.2 5.7 41.5 18.1 33.2
Capitalized development costs 7.0 3.2 10.6 6.6 13.5
Depreciation, amortization and impairment 10.5 9.7 21.2 19.4 39.6
Cash flow from operations -4.3 14.5 -22.9 36.6 97.0
Cash flow from investments -7.6 -9.1 -12.0 -15.1 -26.7
Investment in property, plant and equipment 0.1 4.2 0.6 5.7 10.2
Increase/decrease in cash and cash equivalents -22.7 3.5 -50.4 18.3 62.5
Amounts in DKK million Q2 2023/24 Q2 2022/23 H1 2023/24 H1 2022/23 FY 2022/23
--- --- --- --- --- ---
Key ratios (percentage)
Growth in net turnover -30.4% 34.0% -46.6% 48.6% 18.0
Profit margin -7.7% -1.1% -24.5% 7.8% 8.7
Return on invested capital(2) 3.4% 38.3% 3.4% 38.3% 28.7
Return on equity(3) -2.6% 17.1% -2.6% 17.1% 13.2
Equity ratio 69.7% 63.3% 69.7% 63.3% 65.2
Employment
Average number of full-time employees 291 295 295 294 299
Average number of FTE employed directly 259 262 262 262 267
Revenue per employee (DKK '000)(3) 430 610 702 1,318 2,618
Operating profit per employee (DKK '000)(3) -33 -7 -172 103 227
Shares (number of shares in thousands)
Average number of shares in distribution 8,114 8,200 8,158 8,191 8,200
Average number of diluted shares 8,087 8,216 8,112 8,200 8,195
Share data (DKK per share at DKK 5)
Profit/loss for the year (EPS), per share(3) -0.8 -0.4 -5.0 1.8 5.7
Profit/loss for the year, diluted (DEPS), per share(3) -0.8 -0.4 -5.0 1.8 5.7
Dividends, per share - - - - -
Equity value, per share 40.4 42.2 40.4 42.2 45.9
Listed price, per share 97.2 139.8 97.2 139.8 83.6

Note: The Group's financial year runs from 1 October to 30 September. Definitions of the key ratios used are stated in the annual report for 2022/23 in the accounting policies.
(1) Equals total of cash and current equity investments (2) Calculated over a '12 months' period. (3) Not annualized.


RTX interim report for Q2 and H1 2023/24

<

Management report for Q2 and H1 2023/24

Q2 meets expectations, with growing orders and sales, in a market where customer inventories are normalizing and reordering is beginning to pick up.

Revenue

In the second quarter of the financial year, RTX experienced an increasing order intake and have seen revenue picking up, resulting in a Q2 revenue of DKK 125 million, meeting the expectations communicated in the Q1 report (DKK 120-130 million).

Revenue in the current financial year is heavily impacted by the high stock levels at customers, combined with a reduction in order lead times from 18 to 3 months. Consequently, our customers have focused on reducing inventory and returning to a normalized market dynamic with order horizons of typically 3 months, as were found prior to the component crisis and COVID restrictions.

Revenue for H1 of DKK 207 million is considered disappointing by management. However, the increase in revenue during Q2 and the increase in order intake indicates that the market is normalizing. Furthermore, we maintain close relations to our key customers and expand our portfolio with new customers.

Revenue for Q2 2023/24 reached DKK 125 million (Q2 2022/23: DKK 180 million). Revenue for H1 2023/24 amounted to DKK 207 million (H1 2022/23: DKK 387 million).

The positive development in revenue between first and second quarter reflects that a number of customers have reduced their inventories and have started placing new orders. As expected, total revenue for H1 2023/24 is significantly lower than for H1 2022/23. Compared to last year, revenue is negatively impacted by 2.7%, due to the lower USD exchange rate.

  • Enterprise segment: Revenue for Q2 2023/24 reached DKK 81 million (Q2 2022/23: DKK 116 million). Revenue for H1 2023/24 amounted to DKK 125 million (H1 2022/23: DKK 270 million). Revenue for H1 is 54% lower than last year.

img-0.jpeg

Revenue

Q2 2023/24

125 DKKm

-30%

YoY growth

  • ProAudio segment: Revenue for Q2 2023/24 reached DKK 41 million (Q2 2022/23: DKK 53 million). Revenue for H1 2023/24 amounted to DKK 65 million (H1 2022/23: DKK 91 million). Revenue for H1 is 29% lower than last year.

  • Healthcare segment: Revenue for Q2 2023/24 reached DKK 4 million (Q2 2022/23: DKK 12 million). Revenue for H1 2023/24 amounted to DKK 17 million (H1 2022/23: DKK 26 million). Revenue for H1 is 33% lower than last year. High focus and efforts have been invested in completing the strategic agreement in the Healthcare segment in Q1, and developing according to plan in Q2. RTX is currently in a transition phase to next generation products, and we expect to see new product releases over the next years as a consequence of the agreement signed in November 2023.


RTX interim report for Q2 and H1 2023/24

DKK million Q2 23/24 Change (%, YoY) H1 23/24 Change (%, YoY)
Enterprise revenue 80.9 -30.1% 125.4 -53.6%
ProAudio revenue 40.8 -22.7% 64.6 -29.3%
Healthcare revenue 3.5 -69.3% 17.1 -33.4%
Total 125.2 -30.4% 207.1 -46.6%

Gross profit for Q2 2023/24 reached DKK 57 million (Q2 2022/23: DKK 74 million). Gross profit for H1 2023/24 amounted to DKK 89 million (H1 2022/23: DKK 176 million).

Gross margin for Q2 2023/24 reached 46% (Q2 2022/23: 41%). Gross margin for H1 2023/24 reached 43% (H1 2022/23: 45%). The gross margin is impacted by the revenue mix of products.

As anticipated, there is a notable increase in gross margin from Q1 to Q2, driven by both the product mix and the higher total revenue, where semi-variable costs are distributed over more products.

During the next quarters of 2023/24, we expect to see a continuous positive development of gross margin from product mix and total revenue volume, combined with our efforts to improve individual gross margin per product.

img-1.jpeg

Gross profit

Q2 2023/24

57 DKKm

-23%

YoY growth

DKK million Q2 23/24 Change (YoY) H1 23/24 Change (YoY)
Gross profit 57.1 -23.1 % 88.9 -49.4 %
Gross margin 45.6 % 4.4 pp. 42.9 -2.4 pp.

Capacity costs, which consist mainly of staff costs and other external expenses, amounted to DKK 63 million in Q2 2023/24 (Q2 2022/23: DKK 70 million) and DKK 129 million in H1 2023/24 (H1 2022/23: DKK 132 million) before capitalization of development costs.

We have exercised cost cautiousness in capacity costs and organizational development, and in parallel increased customer focused activities. In Q1 2023/24, we launched cost reduction initiatives, of which we start to see the impact. The initiatives reflect a balanced effort to bridge the short-term revenue reduction with the long-term growth ambition, where we need skilled and experienced employees to keep developing our customer portfolio and products.

DKK million Q2 23/24 Change (%, YoY) H1 23/24 Change (%, YoY)
Capacity costs(1) 63.2 -9.2% 129.1 -2.5%
Value of own work capitalized 7.0 117.7% 10.6 61.2%
Depreciation etc.(2) 10.5 8.3% 21.2 9.4%

(1) Staff costs and other external expenses
(2) Depreciation, amortization and impairment

Capitalized development costs: RTX continue to invest in development of new product features and the future product portfolio.

In total, RTX capitalized own development costs of DKK 7 million in Q2 2023/24 (Q2 2022/23: DKK 3 million), and DKK 11 million in H1 2023/24 (H1 2022/23 DKK 7 million).

Depreciations and amortizations amounted to DKK 21 million in H1 2023/24 (H1 2022/23: DKK 19 million) and is a reflection of new product releases and initiated depreciation.

EBITDA for Q2 2023/24 reached DKK 1 million (Q2 2022/23: DKK 8 million). EBITDA for H1 2023/24 amounted to DKK -30 million (H1 2022/23: DKK 50 million). EBITDA for the period is impacted mainly by the revenue level, which is significantly lower than last year, but improving in Q2 compared to Q1.

EBIT for Q2 2023/24 reached DKK -10 million (Q2 2022/23: DKK -2 million). EBIT for H1 2023/24 amounted to DKK -51 million (H1 2022/23: DKK 30 million). The depreciation level is in line with previous periods around DKK 10 million per quarter.

Profit before tax for Q2 2023/24 reached DKK -8 million (Q2 2022/23: DKK -4 million). Profit before tax for H1 2023/24 amounted to DKK -52 million (H1 2022/23: DKK 19 million).


RTX interim report for Q2 and H1 2023/24

DKK million Q2 23/24 Change (YoY) H1 23/24 Change (YoY)
EBITDA 0.9 -6.9 -29.5 -79.4
EBIT -9.6 -7.7 -50.8 -81.2
Profit/loss before tax -7.8 -4.1 -52.2 -71.0
EPS (DKK per share) -0.8 -0.4 -5.0 -6.8

Equity, Assets, Inventory and Cash Flow

Cash flows from operations (CFFO) for Q2 2023/24 reached DKK -4 million (Q2 2022/23: DKK 15 million). CFFO for H1 2023/24 amounted to DKK -23 million (H1 2022/23: DKK 37 million). CFFO was negatively impacted by operating result and positively impacted by the working capital development, with reduction in both inventory and receivables.

DKK million Q2 23/24 Change (%, YoY) H1 23/24 Change (%, YoY)
CFFO (1) -4.3 -129.8% -22.9 -162.6%
Net liquidity position (2) 87.2 -9.4% 87.2 -9.4%

The net liquidity position of RTX amounted to DKK 87 million at the end of H1 2023/24 compared to DKK 138 million at the start of the fiscal year. The level is positively impacted by the reduction in both inventory and receivables and negatively impacted by operating result for the period.

Total assets were DKK 467 million at the end of H1 2023/24 compared to DKK 547 million at the end of H1 2022/23. The decrease in assets is primarily due to reduction in cash and a decrease in receivables due to the lower activity in the period.

The total value of development cost incurred before capitalization of DKK 32.2 million in Q2 2023/24 includes investment in strategic collaboration with a large global Healthcare company regarding a new generation of wireless infrastructure for patient monitoring solutions for the hospital healthcare sector (ref. note 4).

Return on Invested Capital is calculated over a 12 months period, and is impacted by the lower revenue. For H1 2023/24 ROIC was 3% (H1 2022/23: 37%).

The equity ratio of RTX continues to be at a solid level at 70% at the end of H1 2023/24 (H1 2022/23: 60%).

Outlook for 2023/24

RTX maintains the outlook for the financial year 2023/24 as communicated on 13 November 2023 and in our annual report for 2022/23, with revenue of DKK 580-630 million, EBITDA of DKK 45-60 million and EBIT of DKK 5-20 million.

Revenue for 2023/24: 80% of revenue is expected to come from existing products, and 20% from new product and module launches. Q2 showed a revenue

img-2.jpeg
Equity ratio

70%

ROIC

3%

of DKK 125 million and Q1 a revenue of DKK 82 million. The outlook for 2023/24 reflects a stepwise return to a normalized production and delivery pattern. By the end of 2024, we expect to approach a fully normalized run rate of product sales, but it will vary from customer to customer. We expect to continue to see improvements in the coming quarters, particularly in Q4. The outlook is still subject to uncertainties, particularly in the ProAudio segment, combined with the timing for reaching a normalized production and delivery pattern. However, we maintain our outlook for the year, as previously communicated in the 2022/23 annual report.

Gross margin is expected to be positively impacted by the product mix, and negatively impacted by the lower total revenue, compared to last year. Overall the gross margin for 2023/24 is expected to improve during H2.

Capacity costs for 2023/24 are expected to end lower than for 2022/23. This is a result of cost controlling measures implemented by management in Q1 2023/24 and expected to be maintained throughout the year. The impact of the efforts will be most evident in H2 2023/24.

Inventory, comprises components, finished goods, and goods in transit. We expect to see a reduction of component inventory during the rest of 2023/24, as components will be used in sold products and inflow of components is returning to normal practice, where they are sourced by our production partners. The absolute


RTX interim report for Q2 and H1 2023/24

Risks and uncertainties for the 2023/24 financial year

Forward-looking statements:

The above statements on the Group's future conditions, including in particular, future revenue and operating profit (EBITDA), reflect Management's current outlook and carry some uncertainty. These statements can be affected by several risks and uncertainties, which mean that actual developments and results can be materially different from the expectations expressed directly or indirectly in this interim report. These risks and uncertainties include, but are not limited to, general economic conditions and developments, changes in demand for RTX's products and services, competition, technological changes, fluctuations in currencies, component availability and fluctuations in sub-contractor supplies as well as legislative and/or regulatory changes.

size of the inventory reduction depends on development in revenue.

The outlook is based on dialogue with key customers on their expectations for 2023/24, combined with our market insight on new customers and products. The USD FX rate creates some uncertainty regarding the full-year outlook as the vast majority of revenue and cost of sales are USD denominated. For a full list of assumptions behind the outlook, refer to the annual report for 2022/23 (pages 34-35).

Share buyback

Based on the revised capital policy announced on 29 August 2023, RTX announced on 30 November 2023, that RTX would initiate a share buyback program up to DKK 20 million during 2023/24. By the end of Q2 2023/24, 145,040 shares had been purchased under the Safe Harbour Program at a value of DKK 12 million. The program continues up to the announced DKK 20 million under the regulations of Safe Harbour and RTX's capital policy.

RTX A/S

Peter Thostrup
Chair

Peter Røpke
CEO

img-3.jpeg

Financial calendar

Expected publication of financial information for the financial year 2023/24:

28 August 2024
Interim report Q3 2023/24

28 November 2024
Annual report for 2023/24

Enquiries and further information:

CEO, Peter Røpke or
CFO, Mille Tram Lux tel +45 96 32 23 00


RTX interim report for Q2 and H1 2023/24

Income Statement

(non-audited)

Amounts in DKK '000 Note Q2 2023/24 Q2 2022/23 H1 2023/24 H1 2022/23 FY 2022/23
Revenue 3 125,209 179,987 207,109 387,497 782,777
Value of own work capitalized 4 7,016 3,223 10,639 6,601 13,525
Cost of sales -68,156 -105,834 -118,193 -211,876 -424,346
Other external expenses -17,439 -17,982 -36,732 -34,423 -72,419
Staff costs -45,714 -51,577 -92,364 -97,987 -192,013
Operating profit/loss before depreciation and amortization (EBITDA) 916 7,817 -29,541 49,812 107,524
Depreciation, amortization and impairment 4 -10,548 -9,736 -21,247 -19,416 -39,628
Operating profit/loss (EBIT) -9,632 -1,919 -50,788 30,396 67,896
Financial income 5 3,039 677 3,655 3,159 3,840
Financial expenses 5 -1,213 -2,473 -5,062 -14,799 -12,569
Profit/loss before tax -7,806 -3,715 -52,195 18,756 59,167
Tax on profit/loss 1,717 813 11,483 -4,161 -12,452
Profit/loss for the period -6,089 -2,902 -40,712 14,595 46,715
Earnings per share
Earnings per share (DKK) -0.8 -0.4 -5.0 1.8 5.7
Earnings per share, diluted (DKK) -0.8 -0.4 -5.0 1.8 5.7

Statement of Comprehensive Income

(non-audited)

Amounts in DKK '000 Note Q2 2023/24 Q2 2022/23 H1 2023/24 H1 2022/23 FY 2022/23
Profit/loss for the period -6,089 -2,902 -40,712 14,595 46,715
Items that can be reclassified subsequently to the income statement
Exchange rate adjustments of foreign subsidiaries 873 -820 -861 -4,336 -3,289
Fair value adjustment relating to hedging instruments -43 208 70 2,822 1,852
Tax on hedging instruments 10 -46 -15 -621 -407
Fair value of hedging instruments reclassified to the income statement 32 -487 212 -157 -27
Tax on hedging instruments reclassified -7 108 -47 35 6
Other comprehensive income, net of tax 865 -1,037 -641 -2,257 -1,865
Comprehensive income for the period -5,224 -3,939 -41,353 12,338 44,850

RTX interim report for Q2 and H1 2023/24

Balance Sheet

(non-audited)

Amounts in DKK '000 31.03.24 31.03.23 30.09.23
Assets
Own completed development projects 15,399 27,683 27,356
Own development projects in progress 47,865 24,824 19,714
Software 842 - 1,015
Goodwill 7,797 7,797 7,797
Intangible assets 71,903 60,304 55,882
Right-of-use assets (lease assets) 48,595 50,875 51,155
Plant and machinery 16,848 20,649 20,285
Other fixtures, tools and equipment 3,288 3,905 4,165
Leasehold improvements 10,015 10,745 10,665
Tangible assets 78,746 86,174 86,270
Deposits 6,703 6,730 6,757
Deferred tax assets 7,608 1,916 2,161
Other non-current assets 14,311 8,646 8,918
Total non-current assets 164,960 155,124 151,070
Inventories 99,812 112,671 102,167
Trade receivables 103,745 163,207 168,343
Contract development projects in progress 2,782 4,746 4,819
Income taxes 309 - -
Other receivables 2,601 8,959 8,464
Prepaid expenses 5,627 6,005 5,526
Receivables 115,064 182,917 187,152
Current asset investments in the trading portfolio 32,666 31,208 31,029
Current asset investments 32,666 31,208 31,029
Cash at bank and in hand 54,556 65,051 106,671
Total current assets 302,098 391,847 427,019
Total assets 467,058 546,971 578,089
Amounts in DKK '000 31.03.24 31.03.23 30.09.23
--- --- --- ---
Equity and liabilities
Share capital 42,339 42,339 42,339
Share premium account 170,439 170,439 170,439
Currency adjustments 7,990 7,804 8,851
Cash flow hedging -73 362 -293
Retained earnings 104,859 125,509 155,769
Equity 325,554 346,453 377,105
Lease liabilities 48,591 49,621 49,517
Deferred tax liabilities - 3,887 6,154
Provisions 1,389 1,855 1,389
Deferred income 16,710 - -
Other payables - 13,434 724
Non-current liabilities 66,690 68,797 57,784
Lease liabilities 5,481 6,316 6,896
Prepayments received from customers 10,513 16,970 16,113
Trade payables 31,806 61,633 57,599
Contract development projects in progress 4,663 8,952 3,817
Income taxes 158 11,560 17,779
Provisions 2,716 1,793 2,716
Other payables 19,477 24,497 38,280
Current liabilities 74,814 131,721 143,200
Total liabilities 141,504 200,518 200,984
Total equity and liabilities 467,058 546,971 578,089

RTX interim report for Q2 and H1 2023/24

<

Equity Statement

(non-audited)

Amounts in DKK '000 Share capital Share premium Currency adjustments Cash flow hedging Retained earnings Total
Equity at 1 October 2022 42,339 170,439 12,140 -1,717 108,439 331,640
Profit/loss for the period - - - - 14,595 14,595
Exchange rate adjustments of foreign subsidiaries - - -4,336 - - -4,336
Fair value adjustment relating to hedging instruments - - - 2,822 - 2,822
Tax on hedging instruments - - - -621 - -621
Fair value of hedging instruments reclassified to the income statement - - - -157 - -157
Tax on hedging instruments reclassified - - - 35 - 35
Other comprehensive income, net of tax - - -4,336 2,079 - -2,257
Comprehensive income for the period - - -4,336 2,079 14,595 12,338
Share-based remuneration - - - - 2,194 2,194
Deferred tax on equity transactions - - - - 281 281
Other transactions - - - - 2,475 2,475
Equity at 31 March 2023 42,339 170,439 7,804 362 125,509 346,453

Share capital of DKK 42,339,190 consists of 8,467,838 shares at DKK 5 (DKK 43,214,190 consisting of 8,642,838 shares at 31 March 2022). The Group holds 259,031 treasury shares at 31 March 2023 (459,924 shares at 31 March 2022). There are no shares carrying special rights.

Amounts in DKK '000 Share capital Share premium Currency adjustments Cash flow hedging Retained earnings Total
Equity at 1 October 2023 42,339 170,439 8,851 -293 155,769 377,105
Profit/loss for the period - - - - -40,712 -40,712
Exchange rate adjustments of foreign subsidiaries - - -861 - - -861
Fair value adjustment relating to hedging instruments - - - 70 - 70
Tax on hedging instruments - - - -15 - -15
Fair value of hedging instruments reclassified to the income statement - - - 212 - 212
Tax on hedging instruments reclassified - - - -47 - -47
Other comprehensive income, net of tax - - -861 220 - -641
Comprehensive income for the period - - -861 220 -40,712 -41,353
Share-based remuneration - - - - 1,751 1,751
Current tax on equity transactions - - - - - -
Deferred tax on equity transactions - - - - 113 113
Acquisition of treasury shares - - - - -12,062 -12,062
Other transactions - - - - -10,198 -10,198
Equity at 31 March 2024 42,339 170,439 7,990 -73 104,859 325,554

Share capital of DKK 42,339,190 consists of 8,467,838 shares at DKK 5 (DKK 42,339,190 consisting of 8,467,838 shares at 31 March 2023). The Group holds 400,889 treasury shares at 31 March 2024 (259,031 shares at 31 March 2023). There are no shares carrying special rights.


RTX interim report for Q2 and H1 2023/24

Cash Flow Statement

(non-audited)

Amounts in DKK '000 Q2 2023/24 Q2 2022/23 H1 2023/24 H1 2022/23 FY 2022/23
Operating profit/loss (EBIT) -9,632 -1,919 -50,788 30,396 67,896
Reversal of items with no effects on cash flow
Depreciation, amortization and impairment 10,548 9,736 21,247 19,416 39,628
Other items with no effects on cash flow 10,972 1,578 5,092 -6,596 -9,903
Change in working capital
Change in inventories 5,702 5,379 55 -10,418 8,243
Change in receivables -16,228 8,831 72,501 40,715 35,891
Change in trade payables, etc.. -5,725 -2,790 -50,074 -22,457 -31,410
Cash flow from operating activities -4,363 20,815 -1,967 51,056 110,345
Financial income received 369 170 2,056 2,131 2,991
Financial expenses paid -122 -4,660 -5,090 -14,532 -12,944
Income taxes paid -206 -1,816 -17,938 -2,008 -3,400
Cash flow from operations -4,322 14,509 -22,939 36,647 96,992
Investments in own development projects -7,509 -4,933 -11,440 -9,360 -15,442
Acquisition of intangible assets - - - - -1,040
Acquisition of property, plant and equipment -84 -4,231 -614 -5,749 -10,236
Sale of tangible assets - - - - 49
Deposits on leaseholds 9 15 54 87 60
Acquisition / sale of current asset investments in the trading portfolio, net - - -38 -97 -97
Cash flow from investments -7,584 -9,149 -12,038 -15,119 -26,706
Amounts in DKK '000 Q2 2023/24 Q2 2022/23 H1 2023/24 H1 2022/23 FY 2022/23
--- --- --- --- --- ---
Repayment of lease liabilities -1,673 -1,900 -3,369 -3,259 -7,822
Acquisition of treasury shares -9,105 - -12,062 - -
Paid dividend - - - - -
Cash flow from financing activities -10,778 -1,900 -15,431 -3,259 -7,822
Increase/decrease in cash and cash equivalents -22,684 3,460 -50,408 18,269 62,464
Exchange rate adjustments on cash -5,767 995 -1,707 3,057 482
Cash and cash equivalents at the beginning of the period, net 83,007 60,596 106,671 43,725 43,725
Cash and cash equivalents at the end of the period, net 54,556 65,051 54,556 65,051 106,671
Cash and cash equivalents at the end of the period, net are composed as follows:
Cash at bank and in hand 54,556 65,051 54,556 65,051 106,671
Cash and cash equivalents at the end of the period, net 54,556 65,051 54,556 65,051 106,671

RTX interim report for Q2 and H1 2023/24

Notes

1 Accounting policies

The interim report is presented in accordance with IAS 34 "Interim Financial Reporting" as adopted by the EU and additional Danish disclosure requirements for interim reporting of listed companies. An interim report has not been prepared for the Parent.

The accounting policies applied in this interim report are consistent with those applied in the Company's 2022/23 annual report which was presented in accordance with International Financial Reporting Standards (IFRS) as adopted by the EU and additional Danish disclosure requirements for annual reports of listed companies. We refer to the 2022/23 annual report for a more detailed description of the accounting policies.

The applied accounting policies are unchanged compared to the annual report for 2022/23. New or amended standards and interpretations becoming effective for the financial year 2023/24 have no material impact on the interim report.

2 Estimates and assumptions

The preparation of interim reports requires management to make financial estimates and assumptions that affect the application of accounting policy and recognised assets, liabilities, income and expenses. Actual results might be different from these estimates.

The material estimates that management make when applying the accounting principles of the Group and the material uncertainty connected with these estimates and assumptions are unchanged in the preparation of the interim report compared to the preparation of the annual report as per 30 September 2023.

3 Segment information

In accordance with internal reporting, RTX reports on the three target markets segments; Enterprise, ProAudio and Healthcare. Costs are reported by allocating costs directly attributable to the three reportable market segments whereas common functions costs etc. (primarily other external expenses, staff costs and depreciations related to IT, finance, overall management, joint facilities, joint technology projects, and supply chain management) are reported as non-allocated in accordance with internal reporting.

3 Segment information (continued)

Amounts in DKK '000 Q2 2023/24 Q2 2022/23 H1 2023/24 H1 2022/23 FY 2022/23
Revenue
Enterprise 80,868 115,685 125,398 270,478 527,061
ProAudio 40,799 52,765 64,629 91,354 186,070
Healthcare 3,542 11,537 17,082 25,665 69,646
Group 125,209 179,987 207,109 387,497 782,777
EBITDA
Enterprise 21,448 29,036 20,262 93,243 160,811
ProAudio 15,404 19,143 23,725 32,288 70,469
Healthcare 766 1,234 1,082 5,236 29,928
Non-allocated -36,702 -41,596 -74,610 -80,955 -153,684
Group 916 7,817 -29,541 49,812 107,524
EBIT
Enterprise 16,062 24,341 9,445 83,786 141,162
ProAudio 13,947 17,385 20,690 28,918 64,466
Healthcare 514 1,016 566 4,799 29,388
Non-allocated -40,155 -44,661 -81,489 -87,107 -167,120
Group -9,632 -1,919 -50,788 30,396 67,896

RTX interim report for Q2 and H1 2023/24

Notes

3 Segment information (continued)

Amounts in DKK '000 Q2 2023/24 Q2 2022/23 H1 2023/24 H1 2022/23 FY 2022/23
Revenue, geographical segments
Denmark 21,080 5,336 24,631 5,971 12,370
France 11,562 30,622 14,291 77,344 116,908
Germany 17,664 31,380 20,816 55,916 86,215
Other Europe 30,682 24,115 46,897 51,066 98,945
USA 10,101 58,867 42,190 99,458 261,330
Hong Kong 518 6,655 5,506 48,463 93,546
Other Asia and Pacific 33,593 21,454 52,769 46,267 110,413
Other 9 1,558 9 3,012 3,050
Group 125,209 179,987 207,109 387,497 782,777

Revenue distributed to geographic area according to the geographical location of the customer entity being invoiced.

4 Development costs

Amounts in DKK '000 Q2 2023/24 Q2 2022/23 H1 2023/24 H1 2022/23 FY 2022/23
Development cost incurred before capitalization(1) 32,196 5,653 41,529 18,065 33,177
Value of own work capitalized(2) -7,006 -2,747 -10,619 -5,535 -11,789
Total amortization and impairment on development projects 5,918 6,169 11,957 12,222 24,002
Development costs recognized in the profit/loss account 31,108 9,075 42,867 24,752 45,390

(1) Total value of development cost incurred before capitalization of DKK 32.2 million in Q2 2023/24 includes investment in strategic collaboration with a large global Healthcare company regarding a new generation of wireless infrastructure for patient monitoring solutions for the hospital healthcare sector. The investment relates to deferred income of DKK 16.7 million which will be recognized as income on a long-term basis.

(2) Total value of own capitalized of DKK 7.0 million in Q2 2023/24 according to the income statement includes own tangible assets of DKK 0.0 million (Q2 2022/23: DKK 0.5 million). Total value of own capitalized of DKK 10.6 million in H1 2023/24 according to the income statement includes own tangible assets of DKK 0.0 million (H1 2022/23: DKK 1.1 million).


RTX interim report for Q2 and H1 2023/24

Notes

5 Financial items

Amounts in DKK '000 Q2 2023/24 Q2 2022/23 H1 2023/24 H1 2022/23 FY 2022/23
Exchange rate gains (net) 2,074 - - - -
Fair value adjustments of investments in trading portfolio 190 337 1,599 1,028 849
Gain on hedging instruments (net) - - - 1,505 1,094
Other financial income 775 340 2,056 626 1,897
Total financial income 3,039 677 3,655 3,159 3,840
Exchange rate losses (net) - 1,474 3,398 13,288 8,673
Financing element, IFRS 16 586 561 1,182 1,136 2,448
Loss on hedging instruments (net) 406 170 - - -
Other financial costs 221 268 482 375 1,448
Total financial expenses 1,231 2,473 5,062 14,799 12,569

6 Fair value hierarchy for financial instruments

The below indicates the classification of the financial instruments divided in accordance with the fair value hierarchy:

  • Listed prices in an active market for the same type of instrument (level 1)
  • Listed prices in an active market for similar assets or liabilities or other valuation methods, where all significant input is based on observable market data (level 2)
  • Valuation methods, where any significant input is not based on observable market data (level 3)
Amounts in DKK '000 Level 1 Level 2 Level 3 Total
Financial instruments (hedging), liability - -342 - -342
Bonds listed on the stock exchange, in the trading portfolio 32,666 - - 32,666
Financial net assets at fair value at 31 March 2024 32,666 -342 - 32,324
Financial instruments (hedging), asset - 1,231 - 1,231
Bonds listed on the stock exchange, in the trading portfolio 31,208 - - 31,208
Financial net assets at fair value at 31 March 2023 31,208 1,231 - 32,439

Financial hedging instruments comprise standard foreign exchange forward contracts with the USD/DKK exchange rate as the main element affecting the fair value of the contracts.


RTX interim report for Q2 and H1 2023/24

Management's Statement

The Board of Directors and the Executive Board have today considered and adopted the interim report of RTX A/S for the second quarter and first half of the financial year 2023/24 (covering the period 1 October 2023 to 31 March 2024).

The interim report is prepared in accordance with IAS 34, Interim Financial Reporting, as adopted by the EU and additional Danish disclosure requirements for the interim reporting of listed companies. The interim report has not been audited or reviewed by the Company's auditor.

We consider the applied accounting policies appropriate for the interim report to provide, in our opinion, a true and fair view of the Group's assets, liabilities and financial position as of 31 March 2024 and of its financial performance and cash flow for the second quarter and first half of 2023/24.

We consider Management's review to give a true and fair view of the Group's activities and finances, profit/loss for the period and the Group's financial position as a whole, as well as a true and fair description of the most material risks and uncertainties facing the Group.

Noerresundby, 7 May 2024

Executive Board

Peter Røpke
President and CEO

Mille Tram Lux
CFO

Board of Directors

Peter Thostrup
Chair of the Board

Henrik Schimmell
Deputy Chair

Lars Christian Tofft
Board member

Jesper Mailind
Board member

Katja Millard
Board member

Mogens Vedel Hestbæk
Board member

Kevin Harritsø
Employee Representative

Kurt Heick Rasmussen
Employee Representative

Camilla Munk
Employee Representative


Design and production tested

RTX

RTX A/S
Stroemmen 6
9400 Noerresundby
Denmark
rtx.dk